Clinical Laserthermia Systems AB Logo

Clinical Laserthermia Systems AB

Develops minimally invasive, image-guided systems for laser ablation of diseased tissue.

CLS | ST

Overview

Corporate Details

ISIN(s):
SE0022049912 (+3 more)
LEI:
549300TH4O6D9205O691
Country:
Sweden
Address:
Scheelevägen 2, 223 81 Lund

Description

Clinical Laserthermia Systems (CLS) is a medical technology company that develops and commercializes minimally invasive, image-guided systems for laser ablation. The company's core product is the TRANBERG® Thermal Therapy System, an integrated platform that includes a mobile laser unit, the Thermoguide™ Workstation for real-time monitoring, and sterile, single-use instruments. This system is designed for the precise thermal destruction of diseased tissue, such as tumors, using laser energy. Key clinical applications include neurosurgery for treating brain lesions and urology for the focal therapy of localized prostate cancer. CLS is also advancing immunostimulating laser ablation, a therapy intended to not only destroy the targeted tumor but also to activate the patient's immune system to attack cancer cells systemically.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Clinical Laserthermia Systems AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Clinical Laserthermia Systems AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Clinical Laserthermia Systems AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-23 Hans von Celsing Other Sell 4,000 15,200.00 SEK

Peer Companies

Acarix Logo
Develops AI-powered acoustic devices for non-invasive diagnosis of coronary artery disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops and sells advanced radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a non-invasive device to monitor blood sugar by analyzing exhaled breath.
Poland
AME
Agfa-Gevaert NV Logo
Develops imaging systems, IT solutions, and advanced materials for various industries.
Belgium
AGFB
Alcon AG Logo
A medical company specializing in surgical equipment and vision care products.
Switzerland
ALC
Arcoma AB Logo
Develops and produces complete digital radiography (DR) systems and radiology solutions.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops medical aesthetic devices using HIFU, RF, and ultrasonic technologies.
South Korea
450950
Baird Medical Investment Holdings Ltd Logo
Develops and sells minimally invasive microwave ablation devices for tumor treatment.
United States of America
BDMD
Beta Bionics, Inc. Logo
Develops and commercializes automated insulin delivery systems for diabetes management.
United States of America
BBNX
BIO PROTECH INC. Logo
Manufacturer of medical equipment, disposable supplies, and bio-medical sensors.
South Korea
199290

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.